TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 22438430

Group type: EXPERIMENTAL
Intervention: Everolimus-eluting stents
Number of subjects: 3687

Group type: COMPARATOR
Intervention: Paclitaxel-eluting stents
Number of subjects: 3687

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 3687
Study: 20805210

Group type: EXPERIMENTAL
Intervention: 9.4% tetrahydrocannabinol
Number of subjects: 23

Group type: COMPARATOR
Intervention: 0% tetrahydrocannabinol
Number of subjects: 23
Study: 18054471

Group type: EXPERIMENTAL
Intervention: CHHiP IMRT planning
Number of subjects: 16

Group type: COMPARATOR
Intervention: RT-01 planning
Number of subjects: 16
Study: 17021791

Group type: EXPERIMENTAL
Intervention: Total thyroidectomy (group 1)
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: Near-total thyroidectomy (group 2)
Number of subjects: 216
Study: 12929292

Group type: EXPERIMENTAL
Intervention: Sentinel lymph node biopsy
Number of subjects: 100
Study: 10910027

Group type: EXPERIMENTAL
Intervention: Immunoadsorption using dextran sulfate (DS)‐cellulose columns
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Prednisolone (mean dose 38 mg/day)
Number of subjects: 19
Study: 8843769

Group type: EXPERIMENTAL
Intervention: Intravenous loxiglumide
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 7938670

Group type: EXPERIMENTAL
Intervention: Semantic processing
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Non-semantic processing
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cued completion
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Uncued completion
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Recognition
Number of subjects: 0
Study: 3258993

Group type: EXPERIMENTAL
Intervention: co-trimoxazole (160 mg trimethoprim plus 800 mg sulphamethoxazole) every 12 hours for 15 days
Number of subjects: 50

Group type: COMPARATOR
Intervention: cephalexin (500 mg) every 6 hours for 15 days
Number of subjects: 50
Study: 29857271

Group type: EXPERIMENTAL
Intervention: DAPT (clopidogrel + aspirin)
Number of subjects: 44

Group type: COMPARATOR
Intervention: SAPT (clopidogrel + placebo)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: DAPT
Number of subjects: 44

Group type: COMPARATOR
Intervention: SAPT
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: DAPT and SAPT
Number of subjects: 44
Study: 28258922

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Control participants
Number of subjects: 82
Study: 27261980

Group type: EXPERIMENTAL
Intervention: Foot-bathing therapy at 40°C for 30 minutes daily for four weeks
Number of subjects: 30

Group type: COMPARATOR
Intervention: Foot-bathing therapy at 36.5°C for 30 minutes daily for four weeks (placebo)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 30
Study: 23670066

Group type: EXPERIMENTAL
Intervention: DermaSilk body and tights (group A)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Cotton clothes (group B)
Number of subjects: 22
Study: 21057977

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin (250 or 500 mg twice daily)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study: 20084975

Group type: EXPERIMENTAL
Intervention: Groups A and C conjugate Vaccine with MenB‐OMP
Number of subjects: 458

Group type: COMPARATOR
Intervention: Control group (other vaccine)
Number of subjects: 458
Study: 17454586

Group type: EXPERIMENTAL
Intervention: Chemotherapy (e.g. melphalan, thalidomide)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High-dose treatment with stem-cell support (autologous and allogeneic)
Number of subjects: 0
Study: 15258016

Group type: EXPERIMENTAL
Intervention: Trabeculectomy
Number of subjects: 45

Group type: COMPARATOR
Intervention: Viscocanalostomy
Number of subjects: 45
Study: 11529350

Group type: EXPERIMENTAL
Intervention: Obese children
Number of subjects: 42

Group type: COMPARATOR
Intervention: Non-obese children
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 42
Study: 9764894

Group type: EXPERIMENTAL
Intervention: Kangaroo mother care (KMC)
Number of subjects: 285

Group type: COMPARATOR
Intervention: Conventional methods of care (CMC)
Number of subjects: 285
Study: 8567448

Group type: EXPERIMENTAL
Intervention: Binaural noise (65 dB SPL) presented for 408 ms before the click train.
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Ipsilateral noise (65 dB SPL) presented for 408 ms before the click train.
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Contralateral noise (65 dB SPL) presented for 408 ms before the click train.
Number of subjects: 7

Group type: COMPARATOR
Intervention: Without noise condition (baseline).
Number of subjects: 7
Study: 2375668

Group type: EXPERIMENTAL
Intervention: Rhythmic positional biofeedback (BFB)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Electromyographic (EMG) biofeedback
Number of subjects: 37

Group type: COMPARATOR
Intervention: No-treatment control
Number of subjects: 37
Study: 282700

Group type: EXPERIMENTAL
Intervention: Ornipressin (POR 8)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Adrenaline
Number of subjects: 0
Study: 31074328

Group type: EXPERIMENTAL
Intervention: Child-directed reading of The Cat in the Hat
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control model parameters (lower lexical frequency, capitalization, first mention, likelihood of a syntactic boundary)
Number of subjects: 0
Study: 31685285

Group type: EXPERIMENTAL
Intervention: TAU + AE (treatment as usual + aerobic exercises)
Number of subjects: 31

Group type: COMPARATOR
Intervention: TAU (treatment as usual)
Number of subjects: 31
Study: 28627134

Group type: EXPERIMENTAL
Intervention: Eltrombopag
Number of subjects: 159
Study: 26293657

Group type: EXPERIMENTAL
Intervention: Cognitive behavioral therapy group intervention (n=9)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Waitlist control condition (n=10)
Number of subjects: 19
Study: 24068776

Group type: EXPERIMENTAL
Intervention: Postconditioning
Number of subjects: 700

Group type: COMPARATOR
Intervention: Conventional PCI
Number of subjects: 700
Study: 21420283

Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 18
Study: 18803888

Group type: EXPERIMENTAL
Intervention: 100 mg diclofenac sodium
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study: 16480566

Group type: EXPERIMENTAL
Intervention: Cognitive behavioural psychotherapy (CBT)
Number of subjects: 123
Study: 12871871

Group type: COMPARATOR
Intervention: Metformin (2.55 g/day) for 12 months
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Pioglitazone (45 mg/day) + Metformin diet for 10 months
Number of subjects: 13

Group type: COMPARATOR
Intervention: Metformin diet for 26 responders (N=26)
Number of subjects: 13
Study: 10965008

Group type: EXPERIMENTAL
Intervention: Spinal cord stimulation plus physical therapy
Number of subjects: 54

Group type: COMPARATOR
Intervention: Physical therapy alone
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Spinal cord stimulation (only in patients who underwent implantation)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Spinal cord stimulation
Number of subjects: 54
Study: 1840440

Group type: EXPERIMENTAL
Intervention: Piroxicam
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 7233297

Group type: EXPERIMENTAL
Intervention: Prostaglandin E2 (PGE) 4 mg administered as an intrarectal suppository
Number of subjects: 0

Group type: COMPARATOR
Intervention: Intravaginally administered PGE
Number of subjects: 0
Study: 30849931

Group type: EXPERIMENTAL
Intervention: Low-intensity physical activity (20, 2-minute breaks)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Moderate-intensity physical activity (20, 2-minute breaks)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: High-intensity physical activity (20, 2-minute breaks)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sedentary screen-time breaks
Number of subjects: 30
Study: 29116326

Group type: EXPERIMENTAL
Intervention: Single-Radius (SR) implant
Number of subjects: 60

Group type: COMPARATOR
Intervention: Multi-Radius (J-Curve, JC) implant
Number of subjects: 60
Study: 27697868

Group type: EXPERIMENTAL
Intervention: Crowdsourced video intervention
Number of subjects: 1170

Group type: COMPARATOR
Intervention: Social marketing video intervention
Number of subjects: 1170
Study: 24368003

Group type: EXPERIMENTAL
Intervention: Family therapy intervention
Number of subjects: 124

Group type: COMPARATOR
Intervention: Health promotion group intervention
Number of subjects: 124
Study: 21875892

Group type: EXPERIMENTAL
Intervention: CCFES
Number of subjects: 21

Group type: COMPARATOR
Intervention: Cyclic NMES
Number of subjects: 21
Study: 20501479

Group type: EXPERIMENTAL
Intervention: Perindopril-indapamide (4 mg/1.25 mg)
Number of subjects: 10640

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10640
Study: 17954317

Group type: EXPERIMENTAL
Intervention: Dexamethasone 4 mg
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Dexamethasone 8 mg
Number of subjects: 61

Group type: COMPARATOR
Intervention: Control (no drug)
Number of subjects: 61
Study: 15735183

Group type: EXPERIMENTAL
Intervention: Continuous subcutaneous insulin infusion (CSII) with insulin aspart
Number of subjects: 100

Group type: COMPARATOR
Intervention: Multiple daily injection (MDI) therapy with insulin aspart and insulin glargine
Number of subjects: 100
Study: 12521407

Group type: EXPERIMENTAL
Intervention: Active nicotine patch
Number of subjects: 567

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 567
Study: 10435117

Group type: EXPERIMENTAL
Intervention: High-fibre, carbohydrate-rich breakfast
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Low-fibre, carbohydrate-rich breakfast
Number of subjects: 14

Group type: COMPARATOR
Intervention: Fat-rich breakfasts
Number of subjects: 14
Study: 8522408

Group type: EXPERIMENTAL
Intervention: Captopril 6.25 mg orally 15 min before thrombolysis
Number of subjects: 73

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 73
Study: 2678209

Group type: EXPERIMENTAL
Intervention: Total Potential for Hostility (dichotomized into 'low' and 'high')
Number of subjects: 576

Group type: EXPERIMENTAL
Intervention: Stylistic Hostility (antagonistic interpersonal component of hostility)
Number of subjects: 576

Group type: EXPERIMENTAL
Intervention: Dichotomous Potential for Hostility (after adjustment for traditional risk factors)
Number of subjects: 576

Group type: COMPARATOR
Intervention: Global TABP and related paralinguistic attributes
Number of subjects: 576
Study: 7258828

Group type: EXPERIMENTAL
Intervention: Nasal obstruction
Number of subjects: 10
Study: 30361740

Group type: EXPERIMENTAL
Intervention: Ankle-foot orthosis (AFO)
Number of subjects: 26
Study: 28043754

Group type: EXPERIMENTAL
Intervention: High medication adherence
Number of subjects: 92
Study: 27532914

Group type: EXPERIMENTAL
Intervention: Cerebral protection device (filter group)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (no cerebral protection device)
Number of subjects: 100
Study: 24976394

Group type: EXPERIMENTAL
Intervention: Quetiapine (to 600 mg/d)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Quetiapine
Number of subjects: 90
Study: 22950430

Group type: EXPERIMENTAL
Intervention: Estrogen replacement therapy with 1 mg of estradiol hemihydrate (1 mg/day) orally for 6 months
Number of subjects: 60

Group type: COMPARATOR
Intervention: Not taking estrogen (control group)
Number of subjects: 60
Study: 20472123

Group type: EXPERIMENTAL
Intervention: Patient information digital video disk (DVD)
Number of subjects: 106
Study: 18719013

Group type: EXPERIMENTAL
Intervention: Combined hormone replacement therapy (HRT) - Conjugated equine oestrogen 0.625 mg plus medroxyprogesterone acetate 2.5/5.0 mg orally daily for one year
Number of subjects: 3721

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3721
Study: 15955017

Group type: EXPERIMENTAL
Intervention: Reimbursement for nicotine replacement therapy, bupropion and behavioural counselling (intervention group)
Number of subjects: 1266

Group type: COMPARATOR
Intervention: No reimbursement (control group)
Number of subjects: 1266
Study: 12550815

Group type: EXPERIMENTAL
Intervention: Velocity dependent passive plantarflexor resistive torque in adults with brain injury
Number of subjects: 28

Group type: COMPARATOR
Intervention: Velocity dependent passive plantarflexor resistive torque in age-matched controls
Number of subjects: 28
Study: 10352773

Group type: EXPERIMENTAL
Intervention: Dilute epinephrine saline irrigation (1 mg/l)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Normal saline irrigation (placebo)
Number of subjects: 105
Study: 7837863

Group type: EXPERIMENTAL
Intervention: Circumcised group (after DPT)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Circumcised group (after HIB)
Number of subjects: 60
Study: 1646290

Group type: EXPERIMENTAL
Intervention: 100 mg sumatriptan
Number of subjects: 1130

Group type: EXPERIMENTAL
Intervention: 200 mg sumatriptan
Number of subjects: 1130

Group type: EXPERIMENTAL
Intervention: 300 mg sumatriptan
Number of subjects: 1130

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1130
Study: 6409496

Group type: EXPERIMENTAL
Intervention: Intravenous nitroglycerin
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Sublingual nitroglycerin
Number of subjects: 60
Study: 30904852

Group type: EXPERIMENTAL
Intervention: Diluted epinephrine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 28399154

Group type: EXPERIMENTAL
Intervention: Silk garments plus standard care
Number of subjects: 300

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 300
Study: 26941454

Group type: EXPERIMENTAL
Intervention: Telephone-based breastfeeding intervention delivered by lactation educators
Number of subjects: 298

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 298
Study: 23912778

Group type: EXPERIMENTAL
Intervention: Active laser group (n = 20)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo laser group (n = 20)
Number of subjects: 40
Study: 23009302

Group type: EXPERIMENTAL
Intervention: Managed controlled-opioid prescription monitoring program
Number of subjects: 0

Group type: COMPARATOR
Intervention: General information letter notifying prescribers of available managed care resources
Number of subjects: 0
Study: 19952244

Group type: EXPERIMENTAL
Intervention: Group 1 (118 patients) completed self-report questionnaires at four weeks preoperatively, on the day of surgery, and at six weeks and three months postoperatively.
Number of subjects: 174

Group type: COMPARATOR
Intervention: Group 2 (56 patients) completed self-report questionnaires at six weeks and three months postoperatively.
Number of subjects: 174
Study: 18175829

Group type: EXPERIMENTAL
Intervention: Sublingual misoprostol 400 microg
Number of subjects: 349

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 349
Study: 15053909

Group type: EXPERIMENTAL
Intervention: Non-rinsing conditioner (NRC) solely in superficial dentin (SD)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Er:YAG laser (80 mJ/2 Hz) + NRC in superficial dentin (SD)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Er:YAG laser solely in superficial dentin (SD)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Non-rinsing conditioner (NRC) solely in deep dentin (DD)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Er:YAG laser (80 mJ/2 Hz) + NRC in deep dentin (DD)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Er:YAG laser solely in deep dentin (DD)
Number of subjects: 18
Study: 11230838

Group type: EXPERIMENTAL
Intervention: Atorvastatin 10 mg/day (n = 730)
Number of subjects: 1424

Group type: COMPARATOR
Intervention: Simvastatin 10 mg/day (n = 694)
Number of subjects: 1424
Study: 9604107

Group type: EXPERIMENTAL
Intervention: HA-coated stems
Number of subjects: 79

Group type: COMPARATOR
Intervention: Smooth stems
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Porous-coated stems
Number of subjects: 79
Study: 8067763

Group type: EXPERIMENTAL
Intervention: Foscarnet (maintenance therapy)
Number of subjects: 9
Study: 3055923

Group type: EXPERIMENTAL
Intervention: Lovastatin (20 mg twice daily)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 31811995

Group type: COMPARATOR
Intervention: Baseline
Number of subjects: 959

Group type: COMPARATOR
Intervention: Lower levels of adiponectin and higher levels of resistin
Number of subjects: 959
Study: 29600816

Group type: EXPERIMENTAL
Intervention: 2 per cent chlorhexidine with 70 per cent isopropanol (CA)
Number of subjects: 500

Group type: COMPARATOR
Intervention: 70 per cent isopropanol (PA)
Number of subjects: 500
Study: 28126707

Group type: EXPERIMENTAL
Intervention: Antidepressant therapy
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Nurses' recommendations to intensify treatment
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Recommendations to start treatment
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Renal providers' willingness to provide treatment
Number of subjects: 101
Study: 26218871

Group type: EXPERIMENTAL
Intervention: Atomoxetine (ATX)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Osmotic Release Oral System-Methylphenidate (OROS-MPH)
Number of subjects: 43
Study: 23277482

Group type: EXPERIMENTAL
Intervention: Carboplatin-S-1
Number of subjects: 564

Group type: COMPARATOR
Intervention: Carboplatin-paclitaxel
Number of subjects: 564

Group type: EXPERIMENTAL
Intervention: Carboplatin-S-1 (SCC subgroup)
Number of subjects: 564

Group type: COMPARATOR
Intervention: Carboplatin-paclitaxel (SCC subgroup)
Number of subjects: 564

Group type: EXPERIMENTAL
Intervention: Carboplatin-S-1 (non-SCC subgroup)
Number of subjects: 564

Group type: COMPARATOR
Intervention: Carboplatin-paclitaxel (non-SCC subgroup)
Number of subjects: 564
Study: 22007892

Group type: EXPERIMENTAL
Intervention: Acupuncture-like TENS (AL-TENS)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Conventional TENS
Number of subjects: 43

Group type: COMPARATOR
Intervention: Placebo TENS
Number of subjects: 43
Study: 19061291

Group type: EXPERIMENTAL
Intervention: 1 section examined
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: 2 sections examined
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: 3 sections examined
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: 4 sections examined
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: 1 section examined for atherosis
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: 2 sections examined for atherosis
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: 3 sections examined for atherosis
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: 4 sections examined for atherosis
Number of subjects: 53
Study: 15716289

Group type: EXPERIMENTAL
Intervention: Nurse led clinics to promote medical and lifestyle components of secondary prevention
Number of subjects: 1343

Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 1343
Study: 12911180

Group type: EXPERIMENTAL
Intervention: Warmed saline irrigation
Number of subjects: 38

Group type: COMPARATOR
Intervention: Room temperature saline irrigation
Number of subjects: 38
Study: 10555127

Group type: EXPERIMENTAL
Intervention: Topotecan (dl-5) and cytarabine (1 g/m2 over 2 hours; dl-5)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Topotecan (d1-5) followed by etoposide (250 mg/m2 twice daily, d6-7)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Etoposide (250 mg/m2 twice daily dl-2) followed by topotecan (d3-d7)
Number of subjects: 37
Study: 8670317

Group type: EXPERIMENTAL
Intervention: anti-CD5 ricin-linked immunoconjugate (CD5-IC) at doses up to 8 mg/m2/day for 4 days in 1 month
Number of subjects: 104

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 104
Study: 1804789

Group type: EXPERIMENTAL
Intervention: Ofloxacin
Number of subjects: 137

Group type: COMPARATOR
Intervention: Trimethoprim-sulfamethoxazole (TMP/SMX)
Number of subjects: 137
Study: 6833194

Group type: EXPERIMENTAL
Intervention: Amitriptyline
Number of subjects: 22

Group type: COMPARATOR
Intervention: Tranylcypromine
Number of subjects: 22
Study: 30426791

Group type: EXPERIMENTAL
Intervention: Resurfacing hip arthroplasty (RHA)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Total hip arthroplasty (THA)
Number of subjects: 82
Study: 30016328

Group type: EXPERIMENTAL
Intervention: IPTp-DP every 4 weeks (DP4w)
Number of subjects: 291

Group type: EXPERIMENTAL
Intervention: IPTp-DP every 8 weeks (DP8w)
Number of subjects: 291

Group type: COMPARATOR
Intervention: IPTp-SP every 8 weeks (SP8w)
Number of subjects: 291
Study: 27347650

Group type: EXPERIMENTAL
Intervention: Enhanced adherence counseling intervention delivered by nurses from a central call site
Number of subjects: 59
Study: 24810539

Group type: EXPERIMENTAL
Intervention: Patient specific instrumentation (PSI)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Computer-assisted surgery (CAS)
Number of subjects: 60
Study: 23171383

Group type: EXPERIMENTAL
Intervention: Comprehensive resilience intervention implemented in intervention schools.
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group (no intervention).
Number of subjects: 32
Study: 19910627

Group type: EXPERIMENTAL
Intervention: Epidural morphine (2.5 mg)
Number of subjects: 228

Group type: COMPARATOR
Intervention: Epidural saline (placebo)
Number of subjects: 228
Study: 17503979

Group type: EXPERIMENTAL
Intervention: Modafinil
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 12675121

Group type: EXPERIMENTAL
Intervention: Exercise group (n = 32)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Control group (n = 33)
Number of subjects: 62
Study: 11094007

Group type: EXPERIMENTAL
Intervention: Intrathecal morphine and clonidine combination
Number of subjects: 15

Group type: COMPARATOR
Intervention: Intrathecal morphine alone
Number of subjects: 15

Group type: COMPARATOR
Intervention: Intrathecal clonidine alone
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 8880835

Group type: EXPERIMENTAL
Intervention: Opioid antagonist naltrexone (low dose)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Opioid antagonist naltrexone (high dose)
Number of subjects: 45
Study: 1544959

Group type: EXPERIMENTAL
Intervention: Cemented knee arthroplasty
Number of subjects: 29

Group type: COMPARATOR
Intervention: Uncemented knee arthroplasty
Number of subjects: 29
Study: 3885984

Group type: EXPERIMENTAL
Intervention: 10 mg domperidone
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 10 mg metoclopramide
Number of subjects: 60

Group type: COMPARATOR
Intervention: Normal saline (placebo)
Number of subjects: 60